Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Journal of Hepato-Biliary-Pancreatic Sciences|June 14, 2014
Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studiesHiroaki Yanagimoto, Hiroshi Ishii, Yousuke Nakai, et al.
Internal Medicine (Tokyo, Japan)|October 5, 2022
Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic CancerAkiyoshi Kasuga, Masanori Nojima, Takeshi Okamoto, et al.
BJS Open|April 17, 2025
Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative studyYuki Hirose, Atsushi Oba, Yosuke Inoue, et al.
Surgery|October 11, 2025
Exploring the role of CA 19-9 dynamics in pancreatic cancer multidisciplinary treatment: Proposal of the PANC classificationAya Maekawa, Atsushi Oba, Takafumi Mie, et al.
Molecular and Clinical Oncology|December 2, 2015
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survivalHiroki Osumi, Eiji Shinozaki, Masahiko Osako, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 13, 2010
[A case of small pancreatic cancer with intraductal progress]Nobuhiko Fukuba, Koichi Fujita, Shinji Nakayama, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2022
Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trialAkihiro Ohba, Hideki Ueno, Satoshi Shiba, et al.
The Oncologist|October 3, 2020
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study)Naohiro Okano, Junji Furuse, Makoto Ueno, et al.
Cancer Medicine|October 25, 2020
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patientsMakoto Ueno, Shoji Nakamori, Kazuya Sugimori, et al.
Anticancer Research|August 30, 2023
FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study AnalysisAkiko Todaka, Mitsuhito Sasaki, Hideki Ueno, et al.
Pageof 18